Measuring SPIO and Gd contrast agent magnetization using 3 T MRI

NMR in Biomedicine

Volumn 22, Issue 8, 2009, Pages 891-897

  Cantillon Murphy, Pádraig ^a,b   Wald, Lawrence L ^c   Zahn, Markus ^b   Adalsteinsson, Elfar ^b,c,d  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b Department of Electrical Engineering and Computer Science   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d HARVARD MIT DIVISION OF HEALTH SCIENCES AND TECHNOLOGY   (United States)

Author keywords

Contrast agents; Dipole field; Feridex; Magnetization; Magnevist; MRI; Vibrating sample magnetometry

Indexed keywords

ANALYTICAL SOLUTIONS; CONTRAST AGENT; DATA MATCH; DIPOLE FIELD; DIPOLE FIELDS; EDGE EFFECT; FIELD PATTERNS; IMAGING FIELDS; LIVER IMAGING; MAGNETIC SUSPENSION; MAXIMUM FIELD STRENGTH; MR IMAGING; MRI CONTRAST AGENTS; PHASE IMAGE; SUPERPARAMAGNETIC IRON OXIDES; VASCULAR LESIONS; VIBRATING SAMPLE MAGNETOMETRY; WATER REGIONS;

DEIONIZED WATER; GADOLINIUM; IMAGE RECONSTRUCTION; IRON OXIDES; MAGNETIC FLUIDS; MAGNETIC RESONANCE IMAGING; MAGNETIZATION; MAGNETOMETERS; SUPERPARAMAGNETISM; SUSPENSIONS (COMPONENTS); SUSPENSIONS (FLUIDS);

MAGNETS;

GADOLINIUM; GADOLINIUM PENTETATE; IRON OXIDE; SUPERPARAMAGNETIC IRON OXIDE; WATER;

ANALYTIC METHOD; ARTICLE; CONTROLLED STUDY; IMAGE DISPLAY; IMAGE RECONSTRUCTION; INTERMETHOD COMPARISON; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTION; PRIORITY JOURNAL; VIBRATING SAMPLE MAGNETOMETRY;

CONTRAST MEDIA; DEXTRANS; FERROSOFERRIC OXIDE; GADOLINIUM; MAGNETIC RESONANCE IMAGING; MAGNETICS; MAGNETITE NANOPARTICLES; MODELS, THEORETICAL;

EID: 70649088950     PISSN: 09523480     EISSN: 10991492     Source Type: Journal    
DOI: 10.1002/nbm.1412     Document Type: Article

References (17)

1. Weissleder R, Elizondo G, Wittenberg J, Rabito CA, Bengele HH, Josephson L. Ultrasmall superparamagnetic iron oxide: characterization of a new class of contrast agents for MR imaging. Radiology. 1990; 175: 489-493. (Pubitemid 20135290)
2. Feridex Patient Information AMAG Pharmaceutical. www.berlex.com/ html/products/pi/Feridex-PI.pdf
3. Bulte JWM, Kraitchman DL. Iron oxide MR contrast agents for molecular and cellular imaging. NMR Biomed. 2004; 17: 484-499. (Pubitemid 39549426)
4. Kostura L, Kraitchman DL, Mackay AM, Pittenger MF, Bulte JWM. Feridex labeling of mesenchymal stem cells inhibits chondrogenesis but not adipogenesis or osteogenesis. NMR Biomed. 2004; 17: 513-517. (Pubitemid 39549429)
5. Arbab AS, Yocum GT, Rad AM, Khakoo AY, Fellowes V, Read EJ, Frank JA. Labeling of cells with ferumoxides-protamine sulfate complexes does not inhibit function or differentiation capacity of hematopoietic or mesenchymal stem cells. NMR Biomed. 2005; 18: 553-559. (Pubitemid 43013896)
6. Magnevist Patient Information, Bayer Healthcare. htp://berlex. bayerhealthcare.com/html/products/pi/Magnevist-PI.pdf
7. Weinmann HJ, Brasch RC, Press WR, Wesbey GE. Characteristics of gadolinium-DTPA complex: a potential NMR contrast agent. AJR Am J Roentgenol. 1984; 142: 619-624.
8. Wang SC, Wikstrom MG, White DL, Klaveness J, Holtz E, Rongved P, Moseley ME, Brasch RC. Evaluation of Gd-DTPA-labeled dextran as an intravascular MR contrast agent: imaging characteristics in normal rat tissues. Radiology 1990; 175: 483-488. (Pubitemid 20135289)
9. Gillis P, Koenig SH. Transverse Relaxation of Solvent Protons Induced by Magnetized Spheres: Application to Ferritin, Erthrocytes and Magnetite. Magn Reson Med 1987; 5: 232-245.
10. Zahn M. Electromagnetic Field Theory: a problem solving approach. Krieger Publishing Company: Florida, 2003.
11. Weisskoff R, Kiihne S. MRI Susceptometry: Image-Based Measurement of Absolute Susceptibility of MR Contrast Agents and Human Blood. Magn Reson Med 1992; 24: 375-383.
12. Jung CW, Jacobs P. Physical and Chemical Properties of Superparamagnetic Iron Oxide MR Contrast Agents: Ferumoxides, Ferumoxtran, Ferumoxsil. Magn Reson Imaging 1994; 13: 661-674.
13. Chu SC-K, Xu Y, Balschi JA, Springer CS. Bulk Magnetic Susceptibility Shifts in NMR Studies of Compartmentalized Samples: Use of Paramagnetic Reagents. Magn Reson Med 1990; 13: 239-262. (Pubitemid 20110031)
14. Bowen CV, Zhang X, Saab G, Gareau PJ, Rutt BK. Application of the Static Dephasing Regime Theory to Superparamagnetic Iron-Oxide Loaded Cells. Magn Reson Med 2002; 48: 52-61. (Pubitemid 34721587)
15. Haacke EM, Lai S, Reichenbach JR, Kuppusamy K, Hoogenraad FGC, Takeichi H, Lin W. In vivo measurement of blood oxygen saturation using magnetic resonance imaging: a direct validation of the blood oxygen level-dependent concept in functional brain imaging. Hum Brain Mapp 1997; 5: 341-346.
16. Tong KA, Ashwal S, Obenaus A, Nickerson JP, Kido D, Haacke EM. Susceptibility-Weighted MR Imaging: A Review of Clinical Applications in Children. Am J Neuroradiol 2007; 29: 9.
17. Schenck JF. The role of magnetic susceptibility in magnetic resonance imaging: MRI magnetic compatibility of the first and second kinds. Med Phys. 1996; 23: 815-850.